Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Amori RE, Lau J, Pittas AG. Efficacy and safety of incretin therapy in type 2 diabetes. Systematic review and meta-analysis. JAMA 2007;298:194-206.
2. Richter B, Bandeira-Echtler E, Bergenhoff K, Lech CL. Dipeptidyl peptidase-4 (DDP-4) inhibitors for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No. CD006739.
3. Farmacotherapeutisch rapport sitagliptine bij de indicatie diabetes mellitus type 2. www.cvz.nl.
4. Rosenstock J, Kim SW, Baron MA, Camisasca RP, Cressier F, Couturier A, et al. Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes. Diabetes Obes Metab 2007;9:175-85.
5. Farmacotherapeutisch rapport vildagliptine bij de indicatie diabetes mellitus type 2. www.cvz.nl.